Hartmut Kuhn

Jan 10, 2024 | virologyj.biomedcentral.com | Hartmut Kuhn |Maximilian Schreiner |Werner Wenzel |Cengiz Goekeri |Lorenz Scheit |Dominic Rauschning | +7 more

The present study is a post-hoc analysis of a previously published prospective observational study with hospitalized COVID-19 patients (Frontiers in Microbiology: “Serum interleukin-6, procalcitonin, and C-reactive protein at hospital admission can identify patients at low risk for severe COVID-19 progression” [27]). We have added a second cohort of ambulatory mild affected COVID-19 participants (outpatients).

May 15, 2023 | frontiersin.org | Daniela Gabbia |Hartmut Kuhn |Xiao Li

Yuzhen Lu1, Junjie Hu1, Liang Chen1, Shan Li2,3, Ming Yuan1, Xianxiang Tian1*, Peng Cao4* and Zhenpeng Qiu1,5* 1College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China 2Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Hubei University of Medicine, Shiyan, China 3Department of Biochemistry, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, China 4Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of...